IO Biotech Inc. (IOBT)
undefined
undefined%
At close: undefined
0.80
-1.26%
After-hours Dec 13, 2024, 06:53 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -86.08M -71.46M -67.88M -12.04M -10.74M
Depreciation & Amortization 756.00K 540.00K 2.00K - -
Stock-Based Compensation 8.06M 7.04M 1.79M 64.00K 131.00K
Other Working Capital 5.99M 4.12M -4.18M 623.00K 790.00K
Other Non-Cash Items -331.00K -130.00K 26.22M 1.87M 828.00K
Deferred Income Tax - 87.00K -2.00K - -
Change in Working Capital 5.86M 4.19M -776.00K 148.00K 893.00K
Operating Cash Flow -71.74M -59.73M -40.65M -9.96M -8.89M
Capital Expenditures -323.00K -690.00K -153.00K - -
Acquisitions - - - - -
Purchase of Investments - - - - -
Sales Maturities Of Investments - - - - -
Other Investing Acitivies - - - - -
Investing Cash Flow -323.00K -690.00K -153.00K - -
Debt Repayment - - - - -
Common Stock Repurchased - - - - -
Dividend Paid - - - - -
Other Financial Acitivies -3.20M - 137.84M 5.10M 9.01M
Financial Cash Flow 71.86M - 252.95M 5.10M 9.01M
Net Cash Flow 603.00K -68.94M 208.39M -4.44M -125.00K
Free Cash Flow -72.06M -60.42M -40.80M -9.96M -8.89M